Bacterial-Derived Polymer Poly-y-Glutamic Acid (y-PGA)-Based Micro/Nanoparticles as a Delivery System for

Ibrahim R Khalil1,2, Alan T H Burns3, Iza Radecka4

  • 1Faculty of Science and Engineering, University of Wolverhampton, Wulfruna Street, Wolverhampton WV1 1LY, UK. Grazyna.Adamus@cmpw-pan.edu.pl.

Insights

Poly-γ-glutamic acid (γ-PGA) micro/nanoparticles show promise for drug delivery and as antimicrobial agents due to their biocompatibility and controlled release. This review covers γ-PGA

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Nanotechnology

Background:

  • Poly-γ-glutamic acid (γ-PGA) is a biodegradable, non-toxic, and non-immunogenic biopolymer produced by bacteria.
  • Its unique properties and carboxylic acid groups allow for conjugation with therapeutic agents.
  • γ-PGA has found applications in medical, food, and wastewater industries.

Purpose of the Study:

  • To review the structure, properties, and preparation methods of γ-PGA and its derivatives.
  • To highlight the impact of encapsulating antimicrobial and therapeutic agents within γ-PGA micro/nanoparticles.
  • To explore the potential of γ-PGA-based systems in drug delivery and antimicrobial applications.

Main Methods:

  • Literature review focusing on γ-PGA structure, properties, and synthesis.
  • Analysis of studies involving the micro/nanoencapsulation of active agents onto γ-PGA.
  • Examination of the controlled and sustained-release characteristics of γ-PGA formulations.

Main Results:

  • γ-PGA micro/nanoparticles offer controlled and sustained release of encapsulated agents.
  • These particles exhibit low toxicity and excellent biocompatibility with biological systems.
  • The carboxylic groups on γ-PGA facilitate the attachment and conjugation of various drugs and antimicrobials.

Conclusions:

  • γ-PGA-based micro/nanoparticles are highly promising for advanced drug delivery systems.
  • Their inherent biocompatibility and biodegradability make them suitable for biomedical applications.
  • Further research into γ-PGA derivatives can unlock new therapeutic possibilities.

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
67
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
288
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K